Results 1 -
10
of
14
for
mogamulizumab
- Mogamulizumab-kpkc injection is used to treat mycosis fungoides and Sézary syndrome, two types of cutaneous T- ... or has come back after taking other medications. Mogamulizumab-kpkc injection is in a class of medications ...
- A list of cancer drugs approved by the Food and Drug Administration (FDA) for non-Hodgkin lymphoma. The list includes generic names, brand names, and common ...
- Non-Hodgkin lymphoma (NHL) options include chemotherapy, radiation, targeted therapy, plasmapheresis, surveillance, stem cell transplant, and surgery. ...
- Non-Hodgkin lymphoma (NHL) options include chemotherapy, radiation, targeted therapy, plasmapheresis, surveillance, stem cell transplant, and surgery. ...
- Mycosis fungoides and other cutaneous T-cell lymphomas (including Sézary Syndrome)treatment options include photodynamic therapy, radiation therapy, chemotherapy, ...
- Mycosis fungoides and other cutaneous T-cell lymphomas (including Sézary Syndrome)treatment options include photodynamic therapy, radiation therapy, chemotherapy, ...
- Treatment Option Overview for Mycosis Fungoides (Including Sézary Syndrome)
(National Cancer Institute) Mycosis fungoides and other cutaneous T-cell lymphomas (including Sézary Syndrome)treatment options include photodynamic therapy, radiation therapy, chemotherapy, ... - Mycosis fungoides and other cutaneous T-cell lymphomas (including Sézary Syndrome)treatment options include photodynamic therapy, radiation therapy, chemotherapy, ...
- Lymphoma/Specifics ... Lymphoma ... Mycosis fungoides and other cutaneous T-cell lymphomas (including Sézary Syndrome)treatment options include photodynamic therapy, ...
- Lymphoma/Start Here ... Lymphoma ... National Cancer Institute ... Non-Hodgkin lymphoma (NHL) options include chemotherapy, radiation, targeted therapy, plasmapheresis, ...
(National Cancer Institute) 